Indiana Administrative Code › Title 71 - INDIANA HORSE RACING COMMISSION › Article 8 - HUMAN AND EQUINE HEALTH › Rule 1 - Equine Health; Medication Rules › Section 1-5 - Furosemide as a permitted foreign substance

Current through July 10, 2024
Authority: IC
				  4-31-3-9
Affected: IC
				  4-31-12
Sec. 5.
Furosemide may be administered intravenously to a horse,
				  which is entered to compete in a race. Except under the instructions of the
				  official veterinarian or the racing veterinarian for the purpose of removing a
				  horse from the veterinarian's list or to facilitate the collection of a
				  post-race urine sample, furosemide shall be permitted only after the official
				  veterinarian has placed the horse on the furosemide list. In order for a horse
				  to be placed on the furosemide list, the following process must be
				  followed:
(1) After the horse's
				licensed trainer and practicing veterinarian determine that it would be in the
				horse's best interests to race with furosemide they shall notify the official
				veterinarian or his or her designee, using the prescribed form, that they wish
				the horse to be put on the furosemide list.
(2) The form must be received by the official
				veterinarian or his or her designee by the proper time deadlines so as to
				ensure public notification.
(3) A
				horse placed on the official furosemide list must remain on that list unless
				the licensed trainer and practicing veterinarian submit a written request to
				remove the horse from the list. The request must be made to the official
				veterinarian or his or her designee, on the proper form, no later than the time
				of entry.
(4) After a horse has
				been removed from the furosemide list, the horse may not be placed back on the
				list for a period of sixty (60) calendar days unless it is determined to be
				detrimental to the welfare of the horse, in consultation with the official
				veterinarian. If a horse is removed from the official furosemide list a second
				time in a three hundred sixty-five (365) day period, the horse may not be
				placed back on the list for a period of ninety (90) calendar days.
(5) Furosemide shall only be administered on
				association grounds.
(6) Upon the
				request of the regulatory agency designee, the veterinarian administering the
				authorized bleeder medication shall surrender the syringe used to administer
				such medication, which may then be submitted for testing.
(7) Time of treatment. Horses qualified for
				medication and so indicated on the official bleeder list must be treated at
				least four (4) hours prior to post time.
(8) Medication administration. Bleeder
				medication shall be administered by a veterinarian licensed by the commission
				at an intravenous dose level not to exceed five hundred (500) milligrams and no
				less than one hundred fifty (150) milligrams. The executive director or judges
				may designate certain practicing veterinarians to administer furosemide under
				this rule. Such designation may be determined daily, weekly, or for any other
				appropriate time period. Administration of furosemide shall take place in the
				test barn or a specific location otherwise designated by the commission. An
				association employee shall be present and observe the drawing of furosemide
				into a syringe. The administering veterinarian shall provide a factory sealed
				bottle of furosemide from which the draws shall be made. The trainer of the
				horse receiving furosemide or his or her authorized representative or employee
				shall be present during furosemide administration. The association shall
				establish track rules for furosemide administrations that are consistent with
				these regulations.
(9) Out-of-state
				horses. A bleeder horse shipped into the state from another jurisdiction may be
				automatically eligible to receive furosemide provided that the jurisdiction
				from which it was shipped qualified it as a bleeder using criteria satisfactory
				to this state. The USTA, the breed registry foal certificate, or bleeder
				certificate may be utilized in determining a horse's eligibility to receive
				furosemide.
(10) The test level of
				furosemide under this rule shall not be in excess of one hundred (100)
				nanograms per milliliter of serum or plasma and shall not be below a urine
				specific gravity of one and ten-thousandths (1.010). If an insufficient volume
				of urine is obtained, a positive test shall be based upon quantitative testing
				performed on blood serum or plasma only. Split sample testing shall be
				quantitative and be performed on blood serum or plasma only.